Register for real-time alerts, custom portfolio, and market movers
The current AKTX market cap is 37.88M. The company's latest EPS is USD -0.4944 and P/E is -3.09.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 199k | 556k | 0 | 0 | 330k |
| Operating Income | -16.78M | -17.45M | -17.24M | -25.4M | -19.73M |
| Net Income | -16.85M | -17.08M | -17.42M | -17.01M | -12.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.48M | 14.61M | 11.65M | 16.22M | 5.57M |
| Total Liabilities | 6.47M | 5.22M | 6.09M | 10.98M | 4.58M |
| Total Equity | 8k | 9.38M | 5.56M | 5.24M | 988k |
| Market Cap | 37.88M |
| Price to Earnings Ratio | -3.09 |
| Price to Sales Ratio | 115.04 |
| Price to Cash Ratio | 9.85 |
| Price to Book Ratio | 38.34 |
| Dividend Yield | - |
| Shares Outstanding | 24.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.01 (41.74%) |
| Company Name | Akari Therapeutics PLC |
| Address |
highdown house yeoman west sussex BN99 3HH |
| Website | https://www.akaritx.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
